INTEGRA LIFESCIENCES HOLDINGS CORP
Nasdaq: IARTSurgical & Medical Instruments & Apparatus · Entity-resolved by Clous
Key financials
Short interest & fails
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
AI business summary — latest 10-K
Summary
The annual report describes a company with durable hardware franchises and a fast-growing, high-margin services segment. Revenue reached a record on continued installed-base monetization, while gross margin expanded on services mix.
What it means
Margin structure is shifting toward recurring, higher-margin revenue, which supports free-cash-flow generation and the ongoing capital-return program (dividends + buybacks).
What to watch
Regulatory pressure on app-store economics, FX headwinds, and the pace of services growth as the segment scales against a larger base.
Generated from public filings · not investment advice
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $1.56B | $1.54B | $1.61B | $1.64B | +1.5% | 100% |
| Net Income | $180.55M | $67.74M | -$6.94M | -$516.47M | -7337.7% | -32% |
| Total Assets | $3.89B | $3.78B | $4.04B | $3.6B | -10.8% | 220% |
| Equity | $1.8B | $1.59B | $1.55B | $1.04B | -32.5% | 64% |
| Operating Cash Flow | $264.47M | $139.96M | $129.38M | $50.38M | -61.1% | 3% |
| Shares Outstanding | — | — | — | 77.94M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0000917520